• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同肾脏疾病及合并症的腹膜透析患者的死亡原因:中国某中心的一项回顾性临床分析

Causes of death in peritoneal dialysis patients with different kidney diseases and comorbidities: a retrospective clinical analysis in a Chinese center.

作者信息

Zhang Qianying, Ren Hong, Xie Jingyuan, Li Xiao, Huang Xiaomin, Chen Nan

机构信息

Department of Nephrology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China.

出版信息

Int Urol Nephrol. 2014 Jun;46(6):1201-7. doi: 10.1007/s11255-013-0561-5. Epub 2013 Oct 5.

DOI:10.1007/s11255-013-0561-5
PMID:24097274
Abstract

OBJECTIVES

The objective of the study is to identify and compare the different causes of death among peritoneal dialysis (PD) patients varying in baseline characteristics, including gender, age, primary diseases, and comorbidities and to assess risk factors for first-year death.

METHODS

The clinical data of 179 PD patients who were regularly followed up in our hospital and died between January 2006 and February 2011 were retrospectively reviewed.

RESULTS

Median age at PD catheter implantation was 73 years. The most common primary diseases leading to ESRD were diabetic nephropathy (DN; 26.3 %), chronic glomerulonephritis (CGN; 24.6 %), and hypertensive nephropathy (HN; 21.8 %). The main causes of death in the DN and CGN groups were infections (42.6 %) and cardiocerebrovascular accidents (34.1 %), respectively. Patients with systemic vasculitis (SV) had the highest mortality rate from infection (71.4 %). Cox regression model showed that, compared with patients with CGN, those who had primary disease of DN, renal amyloidosis, multiple myeloma, or vasculitis were at higher risk of first-year death. Cerebrovascular disease, chronic heart failure, and/or lower serum albumin at baseline were also risk factors for first-year death.

CONCLUSIONS

The main causes of death in PD patients with DN and CGN were infections and cardiocerebrovascular accidents, respectively. Risk factors for first-year death included the primary diseases, cerebrovascular diseases, chronic heart failure, and lower serum albumin at baseline.

摘要

目的

本研究的目的是识别并比较腹膜透析(PD)患者中因基线特征(包括性别、年龄、原发性疾病和合并症)不同而导致的不同死亡原因,并评估第一年死亡的危险因素。

方法

回顾性分析了2006年1月至2011年2月期间在我院定期随访并死亡的179例PD患者的临床资料。

结果

PD导管植入时的中位年龄为73岁。导致终末期肾病(ESRD)的最常见原发性疾病为糖尿病肾病(DN;26.3%)、慢性肾小球肾炎(CGN;24.6%)和高血压肾病(HN;21.8%)。DN组和CGN组的主要死亡原因分别为感染(42.6%)和心脑血管意外(34.1%)。系统性血管炎(SV)患者的感染死亡率最高(71.4%)。Cox回归模型显示,与CGN患者相比,患有DN、肾淀粉样变性、多发性骨髓瘤或血管炎原发性疾病的患者第一年死亡风险更高。脑血管疾病、慢性心力衰竭和/或基线时血清白蛋白水平较低也是第一年死亡的危险因素。

结论

DN和CGN的PD患者主要死亡原因分别为感染和心脑血管意外。第一年死亡的危险因素包括原发性疾病、脑血管疾病、慢性心力衰竭和基线时血清白蛋白水平较低。

相似文献

1
Causes of death in peritoneal dialysis patients with different kidney diseases and comorbidities: a retrospective clinical analysis in a Chinese center.不同肾脏疾病及合并症的腹膜透析患者的死亡原因:中国某中心的一项回顾性临床分析
Int Urol Nephrol. 2014 Jun;46(6):1201-7. doi: 10.1007/s11255-013-0561-5. Epub 2013 Oct 5.
2
Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study.中国东部地区初始透析模式对终末期肾病患者生存的影响:一项倾向评分匹配研究。
BMC Nephrol. 2020 Jul 29;21(1):310. doi: 10.1186/s12882-020-01909-3.
3
Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan.高血压性肾硬化导致初治透析患者高死亡率的影响:日本爱知县的一项多中心前瞻性队列研究
Clin Exp Nephrol. 2018 Dec;22(6):1360-1370. doi: 10.1007/s10157-018-1592-0. Epub 2018 Jun 7.
4
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
5
[Etiologic and relevant factor analysis of 1,622 ESRD patients with hemodialysis in Hunan province].[湖南省1622例血液透析终末期肾病患者的病因及相关因素分析]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Jun;31(3):400-3.
6
Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.接受长期透析的多发性骨髓瘤或轻链淀粉样变性患者的生存及肾脏恢复趋势
Clin J Am Soc Nephrol. 2016 Mar 7;11(3):431-41. doi: 10.2215/CJN.06290615. Epub 2016 Jan 4.
7
Patient characteristics and outcomes by GN subtype in ESRD.终末期肾病中肾小球肾炎亚型的患者特征及预后
Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1170-8. doi: 10.2215/CJN.11261114. Epub 2015 Jun 19.
8
Effects of AA amyloidosis on survival in peritoneal dialysis.AA 淀粉样变对腹膜透析患者生存的影响。
Kidney Blood Press Res. 2012;36(1):182-90. doi: 10.1159/000343407. Epub 2012 Nov 11.
9
[Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].[近年来加那利群岛新入透析患者的中期生存分析:当前腹膜透析与血液透析的比较]
Nefrologia. 2011;31(2):174-84. doi: 10.3265/Nefrologia.pre2011.Jan.10743.
10
Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?腹膜透析患者行血液透析前死亡是否有影响?
Nefrologia. 2012 May 14;32(3):335-42. doi: 10.3265/Nefrologia.pre2012.Jan.11143. Epub 2012 Apr 17.

引用本文的文献

1
Assisted peritoneal dialysis: a feasible KRT modality for frail older patients with end-stage kidney disease (ESKD).辅助性腹膜透析:一种适合虚弱老年终末期肾病(ESKD)患者的可行肾脏替代治疗(KRT)方式。
Sci Rep. 2021 Jul 22;11(1):14928. doi: 10.1038/s41598-021-94032-8.
2
Analysis of outcome and factors correlated with maintenance peritoneal dialysis.维持性腹膜透析的结局及相关因素分析
J Int Med Res. 2019 Oct;47(10):4683-4690. doi: 10.1177/0300060519862091. Epub 2019 Aug 26.

本文引用的文献

1
Cardiovascular mortality in dialysis patients.透析患者的心血管死亡率。
Adv Perit Dial. 2012;28:56-9.
2
Survival in patients treated by long-term dialysis compared with the general population.长期透析治疗患者与普通人群的生存比较。
Am J Kidney Dis. 2012 Jun;59(6):819-28. doi: 10.1053/j.ajkd.2011.12.023. Epub 2012 Feb 22.
3
Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues.腹膜透析与血液透析:风险、益处和通路问题。
Adv Chronic Kidney Dis. 2011 Nov;18(6):428-32. doi: 10.1053/j.ackd.2011.09.001.
4
The impact of treatment modality on infection-related hospitalization rates in peritoneal dialysis and hemodialysis patients.治疗方式对腹膜透析和血液透析患者感染相关住院率的影响。
Perit Dial Int. 2011 Jul-Aug;31(4):440-9. doi: 10.3747/pdi.2009.00224. Epub 2010 Jul 29.
5
Ischaemic stroke in incident dialysis patients.透析患者中的缺血性脑卒中。
Nephrol Dial Transplant. 2010 Oct;25(10):3343-8. doi: 10.1093/ndt/gfq220. Epub 2010 Apr 22.
6
Factors predicting mortality in elderly patients on dialysis.预测老年透析患者死亡率的因素。
Nephron Clin Pract. 2010;115(1):c28-34. doi: 10.1159/000286347. Epub 2010 Feb 19.
7
The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis.慢性肾脏病、终末期肾病以及透析第一年的发病率和死亡率状况。
Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S5-11. doi: 10.2215/CJN.05980809.
8
Clinical advantages of peritoneal dialysis.腹膜透析的临床优势。
Perit Dial Int. 2009 Feb;29 Suppl 2:S59-61.
9
Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.系统性淀粉样变性中的肾脏受累:一项关于生存和肾脏结局的意大利协作研究。
Nephrol Dial Transplant. 2008 Mar;23(3):941-51. doi: 10.1093/ndt/gfm684. Epub 2007 Oct 19.
10
Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease.老年终末期肾病患者的合并症、治疗选择与预后之间的关联。
Nephrol Dial Transplant. 2007 Nov;22(11):3246-54. doi: 10.1093/ndt/gfm400. Epub 2007 Jul 5.